Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non- Hodgkin's lymphoma, and cancer

World Journal of Hepatology

Volumn 7, Issue 3, 2015, Pages 327-343

  Ferri, Clodoveo ^a   Sebastiani, Marcox ^a   Giuggioli, Dilia ^a   Colaci, Michele ^a   Fallahi, Poupak ^b   Piluso, Alessia ^c   Antonelli, Alessandro ^b   Zignego, Anna Linda ^c  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Diabetes; Hepatitis C virus; Lymphoma; Mixed cryoglobulinemia; Thyroid

Indexed keywords

EID: 84928953101     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v7.i3.327     Document Type: Review

References (134)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-362 [PMID:2523562 DOI: 10.1126/science.2523562]
2. Ferri C, Marzo E, Longombardo G, Lombardini F, Greco F, Bombardieri S. Alpha-interferon in the treatment of mixed cryoglobulinemia patients. International Cancer Update. Focus on Interferon Alfa 2b. Cannes, France. November 1-4, 1990. Eur J Cancer 1991; 27: 81-82 [DOI: 10.1016/0277-5379(91)90583-Y]
3. Pascual M, Perrin L, Giostra E, Schifferli JA. Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 1990; 162:569-570 [PMID: 2115556 DOI: 10.1093/infdis/162.2.569]
4. Ferri C. Mixed cryoglobulinemia. Orphanet J Rare Dis 2008; 3: 25 [PMID: 18796155 DOI: 10.1186/1750-1172-3-25]
5. Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N. Cryoglobulinemia--a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med 1966; 40: 837-856 [PMID: 4956871 DOI: 10.1016/0002-9343(66)90200-2]
6. Dammacco F, Sansonno D, Piccoli C, Racanelli V, D'Amore FP, Lauletta G. The lymphoid system in hepatitis C virus infection:autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy. Semin Liver Dis 2000; 20: 143-157 [PMID: 10946420 DOI: 10.1055/s-2000-9613]
7. Monti G, Galli M, Invernizzi F, Pioltelli P, Saccardo F, Monteverde A, Pietrogrande M, Renoldi P, Bombardieri S, Bordin G. Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias. QJM 1995; 88:115-126 [PMID: 7704562]
8. Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E, Mazzoni A, Pasero G, Bombardieri S, Highfield P. Association between hepatitis C virus and mixed cryoglobulinemia [see comment]. Clin Exp Rheumatol 1991; 9: 621-624 [PMID: 1662567]
9. Zignego AL, Macchia D, Monti M, Thiers V, Mazzetti M, Foschi M, Maggi E, Romagnani S, Gentilini P, Bréchot C. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 1992; 15: 382-386 [PMID: 1332999 DOI: 10.1016/0168-8278(92)90073-X]
10. Ferri C, Monti M, La Civita L, Longombardo G, Greco F, Pasero G, Gentilini P, Bombardieri S, Zignego AL. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 1993; 82: 3701-3704 [PMID: 8260706]
11. Ferri C, Antonelli A, Mascia MT, Sebastiani M, Fallahi P, Ferrari D, Pileri SA, Zignego AL. HCV-related autoimmune and neoplastic disorders: the HCV syndrome. Dig Liver Dis 2007; 39 Suppl 1:S13-S21 [PMID: 17936215 DOI: 10.1016/S1590-8658(07)80005-3]
12. Machida K, Cheng KT, Sung VM, Levine AM, Foung S, Lai MM. Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6. J Virol 2006; 80: 866-874 [PMID: 16378988 DOI: 10.1128/ JVI.80.2.866-874.2006]
13. Peveling-Oberhag J, Arcaini L, Hansmann ML, Zeuzem S. Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management. J Hepatol 2013; 59: 169-177 [PMID: 23542089 DOI: 10.1016/ j.jhep.2013.03.018]
14. Forghieri F, Luppi M, Barozzi P, Maffei R, Potenza L, Narni F, Marasca R. Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. Clin Dev Immunol 2012; 2012: 807351 [PMID: 22844326 DOI: 10.1155/2012/807351]
15. Marcucci F, Mele A. Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities. Blood 2011; 117: 1792-1798 [PMID:20959600 DOI: 10.1182/blood-2010-06-275818]
16. Hartridge-Lambert SK, Stein EM, Markowitz AJ, Portlock CS. Hepatitis C and non-Hodgkin lymphoma: the clinical perspective. Hepatology 2012; 55: 634-641 [PMID: 22120959 DOI: 10.1002/ hep.25499]
17. Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, Grippon P, Hoang C, Valla D, Piette JC. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994; 106: 1291-1300 [PMID: 7513667]
18. Zignego AL, Ferri C, Giannelli F, Giannini C, Caini P, Monti M, Marrocchi ME, Di Pietro E, La Villa G, Laffi G, Gentilini P. Prevalence of bcl-2 rearrangement in patients with hepatitis C virusrelated mixed cryoglobulinemia with or without B-cell lymphomas. Ann Intern Med 2002; 137: 571-580 [PMID: 12353944 DOI: 10.7326/0003-4819-137-7-200210010-00008]
19. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, Abrignani S. Binding of hepatitis C virus to CD81. Science 1998; 282: 938-941 [PMID:9794763 DOI: 10.1126/science.282.5390.938]
20. Gorevic PD. Rheumatoid factor, complement, and mixed cryoglobulinemia. Clin Dev Immunol 2012; 2012: 439018 [PMID:22956968 DOI: 10.1155/2012/439018]
21. Hernandez-Gea V, Toffanin S, Friedman SL, Llovet JM. Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma. Gastroenterology 2013; 144: 512-527 [PMID: 23313965 DOI: 10.1053/j.gastro.2013.01.002]
22. Flores A, Marrero JA. Emerging trends in hepatocellular carcinoma:focus on diagnosis and therapeutics. Clin Med Insights Oncol 2014; 8: 71-76 [PMID: 24899827]
23. Antonelli A, Ferri C, Fallahi P. Thyroid cancer in patients with hepatitis C infection. JAMA 1999; 281: 1588 [PMID: 10235149 DOI: 10.1001/jama.281.17.1588]
24. Antonelli A, Ferri C, Fallahi P, Pampana A, Ferrari SM, Barani L, Marchi S, Ferrannini E. Thyroid cancer in HCV-related chronic hepatitis patients: a case-control study. Thyroid 2007; 17: 447-451 [PMID: 17542674 DOI: 10.1089/thy.2006.0194]
25. Lenzi M, Johnson PJ, McFarlane IG, Ballardini G, Smith HM, McFarlane BM, Bridger C, Vergani D, Bianchi FB, Williams R. Antibodies to hepatitis C virus in autoimmune liver disease:evidence for geographical heterogeneity. Lancet 1991; 338: 277-280 [PMID: 1677111 DOI: 10.1016/0140-6736(91)90418-O]
26. Zignego AL, Ferri C, Giannini C, Monti M, La Civita L, Careccia G, Longombardo G, Lombardini F, Bombardieri S, Gentilini P. Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med 1996; 124: 31-34 [PMID:7503475 DOI: 10.7326/0003-4819-124-1_Part_1-199601010-00006]
27. De Re V, Caggiari L, Simula MP, De Vita S, Mazzaro C, Lenzi M, Massimo GM, Monti G, Ferri C, Zignego AL, Gabrielli A, Sansonno D, Dammacco F, Libra M, Sacchi N, Talamini R, Spina M, Tirelli U, Cannizzaro R, Dolcetti R. Role of the HLA class II: HCVrelated disorders. Ann N Y Acad Sci 2007; 1107: 308-318 [PMID:17804559 DOI: 10.1196/annals.1381.033]
28. Ferri C, Sebastiani M, Giuggioli D, Cazzato M, Longombardo G, Antonelli A, Puccini R, Michelassi C, Zignego AL. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 2004; 33: 355-374 [PMID: 15190522 DOI: 10.1016/j.semarthrit.2003.10.001]
29. Roccatello D, Fornasieri A, Giachino O, Rossi D, Beltrame A, Banfi G, Confalonieri R, Tarantino A, Pasquali S, Amoroso A, Savoldi S, Colombo V, Manno C, Ponzetto A, Moriconi L, Pani A, Rustichelli R, Di Belgiojoso GB, Comotti C, Quarenghi MI. Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis. Am J Kidney Dis 2007; 49: 69-82 [PMID: 17185147 DOI: 10.1053/ j.ajkd.2006.09.015]
30. Monti G, Pioltelli P, Saccardo F, Campanini M, Candela M, Cavallero G, De Vita S, Ferri C, Mazzaro C, Migliaresi S, Ossi E, Pietrogrande M, Gabrielli A, Galli M, Invernizzi F. Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. Arch Intern Med 2005; 165: 101-105 [PMID:15642884 DOI: 10.1001/archinte.165.1.101]
31. Ferri C, Sebastiani M, Saadoun D, Cacoub P. Cryoglobulinemia and hepatitis C virus. In, JWJ Bijsma, editor. EULAR compendium on rheumatic diseases, 2012. Chapter 42; London: BMJ Publishing Group Ltd, 2012: 1042-1071
32. Ferri C, Sebastiani M, Antonelli A, Colaci M, Manfredi A, Giuggioli D. Current treatment of hepatitis C-associated rheumatic diseases. Arthritis Res Ther 2012; 14: 215 [PMID: 22731694 DOI:10.1186/ar3865]
33. Vitali C. Immunopathologic differences of Sjögren's syndrome versus sicca syndrome in HCV and HIV infection. Arthritis Res Ther 2011; 13: 233 [PMID: 21888688 DOI: 10.1186/ar3361]
34. Ramos-Casals M, Loustaud-Ratti V, De Vita S, Zeher M, Bosch JA, Toussirot E, Medina F, Rosas J, Anaya JM, Font J. Sjögren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases. Medicine (Baltimore) 2005; 84: 81-89 [PMID:15758837 DOI: 10.1097/01.md.0000157397.30055.c9]
35. Ioannidis JP, Vassiliou VA, Moutsopoulos HM. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. Arthritis Rheum 2002; 46: 741-747 [PMID: 11920410 DOI: 10.1002/art.10221]
36. Antonelli A, Ferri C, Ferrari SM, Colaci M, Sansonno D, Fallahi P. Endocrine manifestations of hepatitis C virus infection. Nat Clin Pract Endocrinol Metab 2009; 5: 26-34 [PMID: 19079271 DOI:10.1038/ncpendmet1027]
37. Antonelli A, Ferri C, Fallahi P, Giuggioli D, Nesti C, Longombardo G, Fadda P, Pampana A, Maccheroni M, Ferrannini E. Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia. QJM 2004; 97: 499-506 [PMID: 15256607 DOI: 10.1093/qjmed/hch088]
38. Ferri C, Antonelli A, Mascia MT, Sebastiani M, Fallahi P, Ferrari D, Giunti M, Pileri SA, Zignego AL. B-cells and mixed cryoglobulinemia. Autoimmun Rev 2007; 7: 114-120 [PMID:18035320 DOI: 10.1016/j.autrev.2007.02.019]
39. Antonelli A, Baj G, Marchetti P, Fallahi P, Surico N, Pupilli C, Malavasi F, Ferrannini E. Human anti-CD38 autoantibodies raise intracellular calcium and stimulate insulin release in human pancreatic islets. Diabetes 2001; 50: 985-991 [PMID: 11334442 DOI: 10.2337/diabetes.50.5.985]
40. Antonelli A, Rotondi M, Fallahi P, Ferrari SM, Paolicchi A, Romagnani P, Serio M, Ferrannini E. Increase of CXC chemokine CXCL10 and CC chemokine CCL2 serum levels in normal ageing. Cytokine 2006; 34: 32-38 [PMID: 16697212 DOI: 10.1016/ j.cyto.2006.03.012]
41. Antonelli A, Ferrari SM, Fallahi P, Frascerra S, Santini E, Franceschini SS, Ferrannini E. Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves' disease and ophthalmopathy: modulation by peroxisome proliferatoractivated receptor-gamma agonists. J Clin Endocrinol Metab 2009; 94: 1803-1809 [PMID: 19276231 DOI: 10.1210/jc.2008-2450]
42. Antonelli A, Ferri C, Fallahi P, Ferrari SM, Sebastiani M, Ferrari D, Giunti M, Frascerra S, Tolari S, Franzoni F, Galetta F, Marchi S, Ferrannini E. High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection. Am J Gastroenterol 2008; 103: 2488-2494 [PMID: 18775023 DOI:10.1111/j.1572-0241.2008.02040.x]
43. Antonelli A, Delle Sedie A, Fallahi P, Ferrari SM, Maccheroni M, Ferrannini E, Bombardieri S, Riente L. High prevalence of thyroid autoimmunity and hypothyroidism in patients with psoriatic arthritis. J Rheumatol 2006; 33: 2026-2028 [PMID: 17014017]
44. Antonelli A, Fazzi P, Fallahi P, Ferrari SM, Ferrannini E. Prevalence of hypothyroidism and Graves disease in sarcoidosis. Chest 2006; 130: 526-532 [PMID: 16899854 DOI: 10.1378/chest.130.2.526]
45. Antonelli A, Ferri C, Fallahi P, Cazzato M, Ferrari SM, Sebastiani M, Ferrannini E. Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis. Eur J Endocrinol 2007; 156:431-437 [PMID: 17389457 DOI: 10.1530/EJE-06-0591]
46. Antonelli A, Ferri C, Fallahi P, Nesti C, Zignego AL, Maccheroni M. Thyroid cancer in HCV-related mixed cryoglobulinemia patients. Clin Exp Rheumatol 2002; 20: 693-696 [PMID: 12412202]
47. Antonelli A, Bocci G, La Motta C, Ferrari SM, Fallahi P, Fioravanti A, Sartini S, Minuto M, Piaggi S, Corti A, Alì G, Berti P, Fontanini G, Danesi R, Da Settimo F, Miccoli P. Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer. J Clin Endocrinol Metab 2011; 96: E288-E296 [PMID: 21147882 DOI:10.1210/jc.2010-1905]
48. Ferri C, Cutolo M, Zignego AL, Longombardo G, Sulli A, Cavallaro D, Giusti M, Accardo S, Mazzocca A, Pasero G. Role of androgens in HCV-related mixed cryoglobulinemia. Arthritis Rheum 1998; 41: 539A
49. Fattovich G, Giustina G, Favarato S, Ruol A. A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol 1996; 24: 38-47 [PMID: 8834023 DOI:10.1016/S0168-8278(96)80184-X]
50. Ferri C, Bertozzi MA, Zignego AL. Erectile dysfunction and hepatitis C virus infection. JAMA 2002; 288: 698-699 [PMID:12169072 DOI: 10.1001/jama.288.6.698]
51. Fargion S, Piperno A, Cappellini MD, Sampietro M, Fracanzani AL, Romano R, Caldarelli R, Marcelli R, Vecchi L, Fiorelli G. Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology 1992; 16: 1322-1326 [PMID: 1359994 DOI: 10.1002/hep.1840160603]
52. Ferri C, Baicchi U, la Civita L, Greco F, Longombardo G, Mazzoni A, Careccia G, Bombardieri S, Pasero G, Zignego AL. Hepatitis C virus-related autoimmunity in patients with porphyria cutanea tarda. Eur J Clin Invest 1993; 23: 851-855 [PMID: 7511537 DOI:10.1111/j.1365-2362.1993.tb00741.x]
53. O'Reilly FM, Darby C, Fogarty J, O'Moore R, Courtney MG, O' Connor J, Kay EW, Leader M, Fielding JF, Murphy GM. Porphyrin metabolism in hepatitis C infection. Photodermatol Photoimmunol Photomed 1996; 12: 31-33 [PMID: 8884897 DOI: 10.1111/ j.1600-0781.1996.tb00241.x]
54. Gisbert JP, García-Buey L, Pajares JM, Moreno-Otero R. Prevalence of hepatitis C virus infection in porphyria cutanea tarda:systematic review and meta-analysis. J Hepatol 2003; 39: 620-627 [PMID: 12971974 DOI: 10.1016/S0168-8278(03)00346-5]
55. Cribier B, Chiaverini C, Dali-Youcef N, Schmitt M, Grima M, Hirth C, Lacour JP, Chosidow O. Porphyria cutanea tarda, hepatitis C, uroporphyrinogen decarboxylase and mutations of HFE gene. A case-control study. Dermatology 2009; 218: 15-21 [PMID:19001803 DOI: 10.1159/000173696]
56. di Belgiojoso GB, Ferrario F, Landriani N. Virus-related glomerular diseases: histological and clinical aspects. J Nephrol 2002; 15:469-479 [PMID: 12455712]
57. Daghestani L, Pomeroy C. Renal manifestations of hepatitis C infection. Am J Med 1999; 106: 347-354 [PMID: 10190385 DOI:10.1016/S0002-9343(99)00014-5]
58. Uchiyama-Tanaka Y, Mori Y, Kishimoto N, Nose A, Kijima Y, Nagata T, Umeda Y, Masaki H, Matsubara H, Iwasaka T. Membranous glomerulonephritis associated with hepatitis C virus infection: case report and literature review. Clin Nephrol 2004; 61:144-150 [PMID: 14989635 DOI: 10.5414/CNP61144]
59. Nagao Y, Sata M. Hepatitis C virus and lichen planus. J Gastroenterol Hepatol 2004; 19: 1101-1113 [PMID: 15377286 DOI: 10.1046/j.1440-1746.2003.03324.x]
60. Halawani MR. Dermatological manifestations of hepatitis C virus infection in Saudi Arabia. Saudi Med J 2014; 35: 531-537 [PMID:24888650]
61. Ferri C, La Civita L, Cirafisi C, Siciliano G, Longombardo G, Bombardieri S, Rossi B. Peripheral neuropathy in mixed cryoglobulinemia: clinical and electrophysiologic investigations. J Rheumatol 1992; 19: 889-895 [PMID: 1328632]
62. Ishizaka N, Ishizaka Y, Takahashi E, Tooda Ei, Hashimoto H, Nagai R, Yamakado M. Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening. Lancet 2002; 359: 133-135 [PMID: 11809259 DOI: 10.1016/ S0140-6736(02)07339-7]
63. Matsumori A. Hepatitis C virus infection and cardiomyopathies. Circ Res 2005; 96: 144-147 [PMID: 15692092 DOI: 10.1161/01. RES.0000156077.54903.67]
64. García-Buey L, García-Monzón C, Rodriguez S, Borque MJ, García-Sánchez A, Iglesias R, DeCastro M, Mateos FG, Vicario JL, Balas A. Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C. Gastroenterology 1995; 108: 1770-1777 [PMID: 7768382 DOI: 10.1016/0016-5085(95)90139-6]
65. Ferri C, Longombardo G, La Civita L, Greco F, Lombardini F, Cecchetti R, Cagianelli MA, Marchi S, Monti M, Zignego AL. Hepatitis C virus chronic infection as a common cause of mixed cryoglobulinaemia and autoimmune liver disease. J Intern Med 1994; 236: 31-36 [PMID: 8021570 DOI: 10.1111/j.1365-2796.1994. tb01116.x]
66. Fallahi P, Ferrari SM, Giuggioli D, Manfredi A, Mancusi C, Fabiani S, Centanni M, Marchi S, Ferri C, Antonelli A. Thyroid involvement in hepatitis C - associated mixed cryoglobulinemia. Hormones (Athens) 2014; 13: 16-23 [PMID: 24722124]
67. Pozzato G, Mazzaro C, Crovatto M, Modolo ML, Ceselli S, Mazzi G, Sulfaro S, Franzin F, Tulissi P, Moretti M. Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood 1994; 84: 3047-3053 [PMID: 7949176]
68. Ferri C, Monti M, La Civita L, Careccia G, Mazzaro C, Longombardo G, Lombardini F, Greco F, Pasero G, Bombardieri S. Hepatitis C virus infection in non-Hodgkin's B-cell lymphoma complicating mixed cryoglobulinaemia. Eur J Clin Invest 1994; 24: 781-784 [PMID:7534236 DOI: 10.1111/j.1365-2362.1994.tb01077.x]
69. Ferri C, Caracciolo F, Zignego AL, La Civita L, Monti M, Longombardo G, Lombardini F, Greco F, Capochiani E, Mazzoni A. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994; 88: 392-394 [PMID: 7803287 DOI: 10.1111/j.1365-2141.1994.tb05036.x]
70. Luppi M, Grazia Ferrari M, Bonaccorsi G, Longo G, Narni F, Barozzi P, Marasca R, Mussini C, Torelli G. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia. Leukemia 1996; 10: 351-355 [PMID: 8637247]
71. Mazzaro C, Zagonel V, Monfardini S, Tulissi P, Pussini E, Fanni M, Sorio R, Bortolus R, Crovatto M, Santini G, Tiribelli C, Sasso F, Masutti R, Pozzato G. Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol 1996; 94: 544-550 [PMID: 8790157 DOI: 10.1046/j.1365-2141.1996.6912313.x]
72. Musolino C, Campo S, Pollicino T, Squadrito G, Spatari G, Raimondo G. Evaluation of hepatitis B and C virus infections in patients with non-Hodgkin's lymphoma and without liver disease. Haematologica 1996; 81: 162-164 [PMID: 8641648]
73. Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L, Russo D, Falasca E, Botta GA, Baccarani M. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996; 87: 4296-4301 [PMID: 8639788]
74. De Rosa G, Gobbo ML, De Renzo A, Notaro R, Garofalo S, Grimaldi M, Apuzzo A, Chiurazzi F, Picardi M, Matarazzo M, Rotoli B. High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy. Am J Hematol 1997; 55: 77-82 [PMID: 9209002]
75. Zuckerman E, Zuckerman T, Levine AM, Douer D, Gutekunst K, Mizokami M, Qian DG, Velankar M, Nathwani BN, Fong TL. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997; 127: 423-428 [PMID: 9312998 DOI: 10.7326/0003-4819-127-6-199709150-00002]
76. Catassi C, Fabiani E, Coppa GV, Gabrielli A, Centurioni R, Leoni P, Barbato M, Viola F, Martelli M, De Renzo A, Rotoli B, Bertolani P, Federico M, Carroccio A, Iannitto E, Baldassarre M, Guarini A, Guariso G, Favaretto G, Caramaschi P, Ambrosetti A. High prevalence of hepatitis C virus infection in patients with non-Hodgkin's lymphoma at the onset. Preliminary results of an Italian multicenter study. Recenti Prog Med 1998; 89: 63-67 [PMID:9558907]
77. Kashyap A, Nademanee A, Molina A. Hepatitis C and B-cell lymphoma. Ann Intern Med 1998; 128: 695 [PMID: 9537949 DOI:10.7326/0003-4819-128-8-199804150-00022]
78. Luppi M, Longo G, Ferrari MG, Barozzi P, Marasca R, Morselli M, Valenti C, Mascia T, Vandelli L, Vallisa D, Cavanna L, Torelli G. Clinico-pathological characterization of hepatitis C virusrelated B-cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia. Ann Oncol 1998; 9: 495-498 [PMID: 9653489]
79. Cucuianu A, Patiu M, Duma M, Basarab C, Soritau O, Bojan A, Vasilache A, Mates M, Petrov L. Hepatitis B and C virus infection in Romanian non-Hodgkin's lymphoma patients. Br J Haematol 1999; 107: 353-356 [PMID: 10583224 DOI: 10.1046/ j.1365-2141.1999.01692.x]
80. Vallisa D, Bertè R, Rocca A, Civardi G, Giangregorio F, Ferrari B, Sbolli G, Cavanna L. Association between hepatitis C virus and non-Hodgkin's lymphoma, and effects of viral infection on histologic subtype and clinical course. Am J Med 1999; 106:556-560 [PMID: 10335728 DOI: 10.1016/S0002-9343(99)00069-8]
81. Paydas S, Kiliç B, Sahin B, Buğdayci R. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders in Southern Turkey. Br J Cancer 1999; 80: 1303-1305 [PMID:10424729 DOI: 10.1038/sj.bjc.6690522]
82. Harakati MS, Abualkhair OA, Al-Knawy BA. Hepatitis C Virus infection in Saudi Arab patients with B-cell non-Hodgkin's lymphoma. Saudi Med J 2000; 21: 755-758 [PMID: 11423889]
83. Mizorogi F, Hiramoto J, Nozato A, Takekuma Y, Nagayama K, Tanaka T, Takagi K. Hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma. Intern Med 2000; 39: 112-117 [PMID: 10732826 DOI: 10.2169/internalmedicine.39.112]
84. Zucca E, Roggero E, Maggi-Solcà N, Conconi A, Bertoni F, Reilly I, Castelli D, Pedrinis E, Piffaretti JC, Cavalli F. Prevalence of Helicobacter pylori and hepatitis C virus infections among non-Hodgkin's lymphoma patients in Southern Switzerland. Haematologica 2000; 85: 147-153 [PMID: 10681721]
85. Pioltelli P, Gargantini L, Cassi E, Santoleri L, Bellati G, Magliano EM, Morra E. Hepatitis C virus in non-Hodgkin's lymphoma. A reappraisal after a prospective case-control study of 300 patients. Lombart Study Group of HCV-Lymphoma. Am J Hematol 2000; 64: 95-100 [PMID: 10814987]
86. Sánchez Ruiz AC, Yebra Bango M, Portero F, Provencio Pulla M, Miralles Flores C, España Saz P. [Prevalence of hepatitis C virus infection in patients with non-Hodgkin's lymphoma]. Med Clin (Barc) 2001; 116: 333-334 [PMID: 11333763 DOI: 10.1016/ S0025-7753(01)71818-0]
87. Chindamo MC, Spector N, Segadas JA, Pimenta G, Vanderborght B, Morais JC, Milito C, Moraes Coelho HS. Prevalence of hepatitis C infection in patients with non-Hodgkin's lymphomas. Oncol Rep 2002; 9: 657-659 [PMID: 11956646]
88. De Renzo A, Persico E, de Marino F, di Giacomo Russo G, Notaro R, di Grazia C, Picardi M, Santoro L, Torella R, Rotoli B, Persico M. High prevalence of hepatitis G virus infection in Hodgkin's disease and B-cell lymphoproliferative disorders: absence of correlation with hepatitis C virus infection. Haematologica 2002; 87: 714-718; discussion 718 [PMID: 12091122]
89. Imai Y, Ohsawa M, Tanaka H, Tamura S, Sugawara H, Kuyama J, Fukuda K, Yonezawa T, Matsuzawa Y. High prevalence of HCV infection in patients with B-cell non-Hodgkin's lymphoma:comparison with birth cohort- and sex-matched blood donors in a Japanese population. Hepatology 2002; 35: 974-976 [PMID:11915049 DOI: 10.1053/jhep.2002.32149]
90. Gisbert JP, García-Buey L, Pajares JM, Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology 2003; 125: 1723-1732 [PMID: 14724825 DOI: 10.1053/ j.gastro.2003.09.025]
91. Mele A, Pulsoni A, Bianco E, Musto P, Szklo A, Sanpaolo MG, Iannitto E, De Renzo A, Martino B, Liso V, Andrizzi C, Pusterla S, Dore F, Maresca M, Rapicetta M, Marcucci F, Mandelli F, Franceschi S. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study. Blood 2003; 102: 996-999 [PMID:12714514 DOI: 10.1182/blood-2002-10-3230]
92. Yenice N, Güllük F, Arican N, Türkmen S. HCV prevalence in Hodgkin and non-Hodgkin lymphoma cases. Turk J Gastroenterol 2003; 14: 173-176 [PMID: 14655060]
93. Iwata H, Matsuo K, Takeuchi K, Kishi Y, Murashige N, Kami M. High incidences of malignant lymphoma in patients infected with hepatitis B or hepatitis C virus. Haematologica 2004; 89: 368-370 [PMID: 15020283]
94. Gisbert JP, García-Buey L, Arranz R, Blas C, Pinilla I, Khorrami S, Acevedo A, Borque MJ, Pajares JM, Fernández-Rañada JM, Moreno-Otero R. The prevalence of hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Eur J Gastroenterol Hepatol 2004; 16: 135-138 [PMID: 15075985 DOI: 10.1097/00042737-200402000-00003]
95. Talamini R, Montella M, Crovatto M, Dal Maso L, Crispo A, Negri E, Spina M, Pinto A, Carbone A, Franceschi S. Non-Hodgkin's lymphoma and hepatitis C virus: a case-control study from northern and southern Italy. Int J Cancer 2004; 110: 380-385 [PMID:15095303 DOI: 10.1002/ijc.20137]
96. Cowgill KD, Loffredo CA, Eissa SA, Mokhtar N, Abdel-Hamid M, Fahmy A, Strickland GT. Case-control study of non-Hodgkin's lymphoma and hepatitis C virus infection in Egypt. Int J Epidemiol 2004; 33: 1034-1039 [PMID: 15155696 DOI: 10.1093/ije/dyh183]
97. Engels EA, Chatterjee N, Cerhan JR, Davis S, Cozen W, Severson RK, Whitby D, Colt JS, Hartge P. Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study. Int J Cancer 2004; 111: 76-80 [PMID: 15185346 DOI: 10.1002/ijc.20021]
98. de Sanjose S, Benavente Y, Vajdic CM, Engels EA, Morton LM, Bracci PM, Spinelli JJ, Zheng T, Zhang Y, Franceschi S, Talamini R, Holly EA, Grulich AE, Cerhan JR, Hartge P, Cozen W, Boffetta P, Brennan P, Maynadié M, Cocco P, Bosch R, Foretova L, Staines A, Becker N, Nieters A. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol 2008; 6: 451-458 [PMID: 18387498 DOI: 10.1016/ j.cgh.2008.02.011]
99. Spinelli JJ, Lai AS, Krajden M, Andonov A, Gascoyne RD, Connors JM, Brooks-Wilson AR, Gallagher RP. Hepatitis C virus and risk of non-Hodgkin lymphoma in British Columbia, Canada. Int J Cancer 2008; 122: 630-633 [PMID: 17935132 DOI: 10.1002/ijc.23105]
100. Chuang SS, Liao YL, Chang ST, Hsieh YC, Kuo SY, Lu CL, Hwang WS, Lin IH, Tsao CJ, Huang WT. Hepatitis C virus infection is significantly associated with malignant lymphoma in Taiwan, particularly with nodal and splenic marginal zone lymphomas. J Clin Pathol 2010; 63: 595-598 [PMID: 20530156 DOI: 10.1136/ jcp.2010.076810]
101. Libra M, Polesel J, Russo AE, De Re V, Cinà D, Serraino D, Nicoletti F, Spandidos DA, Stivala F, Talamini R. Extrahepatic disorders of HCV infection: a distinct entity of B-cell neoplasia? Int J Oncol 2010; 36: 1331-1340 [PMID: 20428756 DOI: 10.3892/ ijo_00000618]
102. Kang J, Cho JH, Suh CW, Lee DH, Oh HB, Sohn YH, Chi HS, Park CJ, Jang SS, Lee KH, Lee JH, Lee JH, Lee SW, Chung YH, Kim TH, Shin HR, Huh J. High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignancies. Ann Hematol 2011; 90: 159-164 [PMID: 20821327 DOI: 10.1007/s00277-010-1055-5]
103. Nosotti L, D'Andrea M, Pitidis A, Pimpinelli F, Dessanti ML, Pisani F, Vignally P, Petti MC. Hepatitis C virus infection prevalence and liver dysfunction in a cohort of B-cell non-Hodgkin's lymphoma patients treated with immunochemotherapy. Scand J Infect Dis 2012; 44:70-73 [PMID: 21905952 DOI: 10.3109/00365548.2011.611819]
104. Brind AM, Watson JP, Burt A, Kestevan P, Wallis J, Proctor SJ, Bassendine MF. Non-Hodgkin's lymphoma and hepatitis C virus infection. Leuk Lymphoma 1996; 21: 127-130 [PMID: 8907279 DOI: 10.3109/10428199609067589]
105. Hanley J, Jarvis L, Simmonds P, Parker A, Ludlam C. HCV and non-Hodgkin lymphoma. Lancet 1996; 347: 1339 [PMID: 8622540 DOI: 10.1016/S0140-6736(96)90991-5]
106. McColl MD, Singer IO, Tait RC, McNeil IR, Cumming RL, Hogg RB. The role of hepatitis C virus in the aetiology of non-Hodgkins lymphoma--a regional association? Leuk Lymphoma 1997; 26:127-130 [PMID: 9250797]
107. Thalen DJ, Raemaekers J, Galama J, Cooreman MP. Absence of hepatitis C virus infection in non-Hodgkin's lymphoma. Br J Haematol 1997; 96: 880-881 [PMID: 9074442]
108. Ellenrieder V, Weidenbach H, Frickhofen N, Michel D, Prümmer O, Klatt S, Bernas O, Mertens T, Adler G, Beckh K. HCV and HGV in B-cell non-Hodgkin's lymphoma. J Hepatol 1998; 28: 34-39 [PMID:9537861 DOI: 10.1016/S0168-8278(98)80199-2]
109. Timurağlu A, Colak D, Oğünç D, Karadoğan I, Undar L. Hepatitis C virus association with non-Hodgkin's lymphoma. Haematologia (Budap) 1999; 29: 301-304 [PMID: 10438070]
110. Collier JD, Zanke B, Moore M, Kessler G, Krajden M, Shepherd F, Heathcote J. No association between hepatitis C and B-cell lymphoma. Hepatology 1999; 29: 1259-1261 [PMID: 10094973 DOI: 10.1002/hep.510290422]
111. Shariff S, Yoshida EM, Gascoyne RD, Le N, Connors JM, Middleton PJ, Shenkier TN. Hepatitis C infection and B-cell non-Hodgkin's lymphoma in British Columbia: a cross-sectional analysis. Ann Oncol 1999; 10: 961-964 [PMID: 10509159]
112. Udomsakdi-Auewarakul C, Auewarakul P, Sukpanichnant S, Muangsup W. Hepatitis C virus infection in patients with non-Hodgkin lymphoma in Thailand. Blood 2000; 95: 3640-3641 [PMID: 10877553]
113. Hausfater P, Cacoub P, Sterkers Y, Thibault V, Amoura Z, Nguyen L, Ghillani P, Leblond V, Piette JC. Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France. Am J Hematol 2001; 67: 168-171 [PMID: 11391713 DOI:10.1002/ajh.1101]
114. Isikdogan A, Ayyildiz O, Dursun M, Tiftik N, Batun S, Muftuoglu E. Hepatitis C virus in patients with non-Hodgkin's lymphoma in southeastern Anatolia region of Turkey: a prospective case-control study of 119 patients. Leuk Lymphoma 2003; 44: 1745-1747 [PMID:14692528 DOI: 10.1080/1042819031000116724]
115. Giannoulis E, Economopoulos T, Mandraveli K, Giannoulis K, Nikolaides C, Zervou E, Papageorgiou E, Zoulas D, Tourkantonis A, Giannopoulos G, Fountzilas G. The prevalence of hepatitis C and hepatitis G virus infection in patients with B cell non-Hodgkin lymphomas in Greece: a Hellenic Cooperative Oncology Group Study. Acta Haematol 2004; 112: 189-193 [PMID: 15564729 DOI:10.1159/000081270]
116. Sonmez M, Bektas O, Yilmaz M, Durmus A, Akdogan E, Topbas M, Erturk M, Ovali E, Omay SB. The relation of lymphoma and hepatitis B virus/hepatitis C virus infections in the region of East Black Sea, Turkey. Tumori 2007; 93: 536-539 [PMID: 18338485]
117. Okan V, Yilmaz M, Bayram A, Kis C, Cifci S, Buyukhatipoglu H, Pehlivan M. Prevalence of hepatitis B and C viruses in patients with lymphoproliferative disorders. Int J Hematol 2008; 88: 403-408 [PMID: 18836791 DOI: 10.1007/s12185-008-0175-3]
118. Park SC, Jeong SH, Kim J, Han CJ, Kim YC, Choi KS, Cho JH, Lee M, Jung HH, Ki SS, Chang YH, Lee SS, Park YH, Lee KH. High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin's lymphoma in Korea. J Med Virol 2008; 80: 960-966 [PMID: 18428141 DOI: 10.1002/jmv.21168]
119. Varma S, Menon MC, Garg A, Malhotra P, Sharma A, Chawla YK, Dhiman RK. Hepatitis C virus infection among patients with non-Hodgkin's lymphoma in northern India. Hepatol Int 2011; 5:688-692 [PMID: 21484139 DOI: 10.1007/s12072-010-9244-9]
120. Ferri C, Zignego AL, Pileri SA. Cryoglobulins. J Clin Pathol 2002; 55: 4-13 [PMID: 11825916 DOI: 10.1136/jcp.55.1.4]
121. Engels EA. Infectious agents as causes of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2007; 16: 401-404 [PMID:17337646 DOI: 10.1158/1055-9965.EPI-06-1056]
122. Matsuo K, Kusano A, Sugumar A, Nakamura S, Tajima K, Mueller NE. Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies. Cancer Sci 2004; 95: 745-752 [PMID: 15471561 DOI: 10.1111/ j.1349-7006.2004.tb03256.x]
123. Dal Maso L, Franceschi S. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev 2006; 15: 2078-2085 [PMID: 17119031 DOI: 10.1158/1055-9965.EPI-06-0308]
124. Hermine O, Lefrère F, Bronowicki JP, Mariette X, Jondeau K, Eclache-Saudreau V, Delmas B, Valensi F, Cacoub P, Brechot C, Varet B, Troussard X. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002; 347: 89-94 [PMID: 12110736 DOI: 10.1056/ NEJMoa013376]
125. Mazzaro C, De Re V, Spina M, Dal Maso L, Festini G, Comar C, Tirelli U, Pozzato G. Pegylated-interferon plus ribavirin for HCV-positive indolent non-Hodgkin lymphomas. Br J Haematol 2009; 145: 255-257 [PMID: 19239472 DOI: 10.1111/ j.1365-2141.2008.07565.x]
126. Arcaini L, Vallisa D, Rattotti S, Ferretti VV, Ferreri AJ, Bernuzzi P, Merli M, Varettoni M, Chiappella A, Ambrosetti A, Tucci A, Rusconi C, Visco C, Spina M, Cabras G, Luminari S, Tucci M, Musto P, Ladetto M, Merli F, Stelitano C, d'Arco A, Rigacci L, Levis A, Rossi D, Spedini P, Mancuso S, Marino D, Bruno R, Baldini L, Pulsoni A. Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi. Ann Oncol 2014; 25: 1404-1410 [PMID: 24799461 DOI: 10.1093/annonc/mdu166]
127. Cacoub P, Lidove O, Maisonobe T, Duhaut P, Thibault V, Ghillani P, Myers RP, Leger JM, Servan J, Piette JC. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 2002; 46: 3317-3326 [PMID:12483738 DOI: 10.1002/art.10699]
128. Saadoun D, Resche-Rigon M, Thibault V, Piette JC, Cacoub P. Antiviral therapy for hepatitis C virus--associated mixed cryoglobulinemia vasculitis: a long-term followup study. Arthritis Rheum 2006; 54: 3696-3706 [PMID: 17075881 DOI: 10.1002/ art.22168]
129. Mazzaro C, Zorat F, Caizzi M, Donada C, Di Gennaro G, Maso LD, Carniello G, Virgolini L, Tirelli U, Pozzato G. Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study. J Hepatol 2005; 42: 632-638 [PMID: 15826710 DOI: 10.1016/j.jhep.2004.10.031]
130. Pietrogrande M, De Vita S, Zignego AL, Pioltelli P, Sansonno D, Sollima S, Atzeni F, Saccardo F, Quartuccio L, Bruno S, Bruno R, Campanini M, Candela M, Castelnovo L, Gabrielli A, Gaeta GB, Marson P, Mascia MT, Mazzaro C, Mazzotta F, Meroni P, Montecucco C, Ossi E, Piccinino F, Prati D, Puoti M, Riboldi P, Riva A, Roccatello D, Sagnelli E, Scaini P, Scarpato S, Sinico R, Taliani G, Tavoni A, Bonacci E, Renoldi P, Filippini D, Sarzi-Puttini P, Ferri C, Monti G, Galli M. Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients. Autoimmun Rev 2011; 10: 444-454 [PMID:21303705 DOI: 10.1016/j.autrev.2011.01.008]
131. Gragnani L, Fabbrizzi A, Triboli E, Urraro T, Boldrini B, Fognani E, Piluso A, Caini P, Ranieri J, Monti M, Laffi G, Zignego AL. Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: a prospective, controlled pilot study. Dig Liver Dis 2014; 46: 833-837 [PMID: 24953206 DOI: 10.1016/ j.dld.2014.05.017]
132. Ferri C, Cacoub P, Mazzaro C, Roccatello D, Scaini P, Sebastiani M, Tavoni A, Zignego AL, De Vita S. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature. Autoimmun Rev 2011; 11:48-55 [PMID: 21821153 DOI: 10.1016/j.autrev.2011.07.005]
133. De Vita S, Quartuccio L, Isola M, Mazzaro C, Scaini P, Lenzi M, Campanini M, Naclerio C, Tavoni A, Pietrogrande M, Ferri C, Mascia MT, Masolini P, Zabotti A, Maset M, Roccatello D, Zignego AL, Pioltelli P, Gabrielli A, Filippini D, Perrella O, Migliaresi S, Galli M, Bombardieri S, Monti G. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum 2012; 64: 843-853 [PMID: 22147661 DOI:10.1002/art.34331]
134. Dammacco F, Tucci FA, Lauletta G, Gatti P, De Re V, Conteduca V, Sansonno S, Russi S, Mariggiò MA, Chironna M, Sansonno D. Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a longterm study. Blood 2010; 116: 343-353 [PMID: 20308602 DOI:10.1182/blood-2009-10-245878]